| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
81,103 |
60,407 |
$2.90M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
32,392 |
27,344 |
$1.61M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,254 |
6,168 |
$487K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,544 |
5,441 |
$421K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,088 |
4,998 |
$404K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
22,285 |
10,381 |
$237K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,247 |
3,075 |
$233K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,917 |
5,430 |
$229K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,685 |
6,971 |
$193K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,598 |
9,132 |
$130K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,842 |
1,685 |
$76K |
| 92557 |
|
2,424 |
2,412 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,124 |
8,547 |
$59K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
745 |
738 |
$55K |
| 99429 |
|
2,124 |
2,108 |
$55K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,644 |
6,534 |
$53K |
| 92552 |
|
4,765 |
4,722 |
$42K |
| 90461 |
|
19,027 |
4,894 |
$41K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
674 |
670 |
$39K |
| 17110 |
|
374 |
348 |
$33K |
| 99381 |
|
266 |
264 |
$18K |
| 92551 |
|
4,128 |
4,037 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,435 |
1,343 |
$17K |
| 87807 |
|
1,244 |
1,173 |
$13K |
| 0071A |
|
242 |
238 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
91 |
91 |
$8K |
| 99051 |
|
3,417 |
3,228 |
$7K |
| 0072A |
|
169 |
169 |
$7K |
| 96160 |
|
5,465 |
5,431 |
$6K |
| 81003 |
|
3,287 |
3,070 |
$6K |
| 80061 |
Lipid panel |
628 |
622 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
761 |
751 |
$5K |
| 81025 |
|
640 |
604 |
$5K |
| 97169 |
|
165 |
165 |
$4K |
| 86318 |
|
303 |
300 |
$4K |
| 82947 |
|
819 |
798 |
$3K |
| 96161 |
|
4,551 |
4,514 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
56 |
56 |
$663.78 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
575 |
532 |
$414.84 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
633 |
606 |
$346.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
25 |
$284.57 |
| 86580 |
|
20 |
20 |
$129.20 |
| 81002 |
|
24 |
24 |
$49.64 |
| 90686 |
|
2,764 |
2,749 |
$1.79 |
| 90651 |
|
527 |
527 |
$0.26 |
| 90671 |
|
221 |
220 |
$0.15 |
| 90734 |
|
1,423 |
1,416 |
$0.11 |
| 90715 |
|
893 |
888 |
$0.09 |
| 90621 |
|
41 |
41 |
$0.08 |
| 90620 |
|
14 |
14 |
$0.04 |
| 90658 |
|
12 |
12 |
$0.01 |
| 90710 |
|
1,649 |
1,636 |
$0.01 |
| 90633 |
|
1,709 |
1,700 |
$0.01 |
| 90656 |
|
188 |
188 |
$0.01 |
| 90700 |
|
579 |
573 |
$0.00 |
| 90648 |
|
2,493 |
2,479 |
$0.00 |
| 90681 |
|
628 |
622 |
$0.00 |
| 90707 |
|
13 |
13 |
$0.00 |
| 90670 |
|
2,776 |
2,759 |
$0.00 |
| 90649 |
|
518 |
516 |
$0.00 |
| 83655 |
|
17 |
17 |
$0.00 |
| 90744 |
|
12 |
12 |
$0.00 |
| 90696 |
|
727 |
718 |
$0.00 |
| 90723 |
|
1,744 |
1,735 |
$0.00 |
| 96127 |
|
284 |
283 |
$0.00 |
| 90680 |
|
797 |
794 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
27 |
25 |
$0.00 |
| 90698 |
|
326 |
322 |
$0.00 |
| 91307 |
|
476 |
457 |
$0.00 |
| 85027 |
|
26 |
26 |
$0.00 |
| 90716 |
|
14 |
14 |
$0.00 |